Tenaya Therapeutics is a biotechnology company. The Company was founded in 2016 by leading cardiovascular scientists from the David J. Gladstone Institutes and the University of Texas Southwestern Medical Center.
We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease. Our vision is to change the treatment paradigm for heart disease, and in doing so improve and extend the lives of millions of individuals and families fighting this debilitating disease. We are advancing a pipeline of disease-modifying therapies developed using our product platforms and core internal capabilities to target defined sub-populations of patients with rare or highly prevalent forms of heart disease.
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $198M
Founded date: 2016
Investors 4
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.03.2021 | Series C | $106M | - |
| 03.10.2019 | Series B | $92M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 18.03.2024 | Tenaya Therapeutics Reports Fourth Quarter and Full Year 202... | Initial Data from Ongoing MyPeak™-1 Phase 1b of TN-201 for MYBPC3-associated HCM Expected in Second ... | einpresswi... |
| 02.03.2021 | Tenaya Therapeutics secures $106M | Tenaya Therapeutics has raised a $106 million Series C led by RTW Investments. The Bay Area company ... | pitchbook.... |
| 02.03.2021 | Tenaya Therapeutics Secures $106M in Series C | SOUTH SAN FRANCISCO, CA, Tenaya Therapeutics, announced that it has secured $106 million in Series... | vcnewsdail... |
| 01.03.2021 | Tenaya grabs $106M top-up to push heart disease gene therapi... | With another $106 million in the bank, heart-focused Tenaya Therapeutics is ready to talk targets. T... | fiercebiot... |
| 01.03.2021 | Daily funding roundup - March 1st, 2021 | Skydio raised $170M; Artiva landed $120M; FogPharma secured $107M; Axonius picks up $100M Skydio: Sk... | vator.tv/n... |
| 01.03.2021 | Tenaya Therapeutics Raises $106M in Series C Funding | Tenaya Therapeutics, a South San Francisco, CA-based biotechnology company to discover, develop and ... | finsmes.co... |
| 01.03.2021 | Tenaya grabs $106M top-up to push heart disease gene therapi... | With another $106 million in the bank, heart-focused Tenaya Therapeutics is ready to talk targets. T... | fiercebiot... |
| 11.10.2019 | Tenaya Therapeutics Raises $92 Million In Funding To Deliver... | Tenaya Therapeutics, a company that is aiming to discover, develop, and deliver curative therapies t... | pulse2.com... |
| 04.10.2019 | Tenaya Therapeutics Grabs $92M | SOUTH SAN FRANCISCO, CA, Tenaya announced the successful completion of a $92 million Series B fina... | vcnewsdail... |
| 03.10.2019 | Tenaya Therapeutics bags $92M to develop triple threat for h... | Tenaya CEO Faraz Ali (Tenaya Therapeutics) Although heart disease remains the leading cause of death... | fiercebiot... |
Show more